Phase 2 Start~month

Phase 2 Start: Phase II, Double-Blind, Placebo-Controlled, Randomized Trial Examining Natrunix in Combination With

Indication
Rheumatoid Arthritis

Other upcoming events for XBIT

Phase 2 StartPhase 2 Start: Phase II, Double-Blind, Placebo-Controlled, Randomized Study Evaluating the Efficacy and Safety of V

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: Phase II, Double-Blind, Placebo-Controlled, Randomized Trial Examining Natrunix in Combination With — XBIT Phase 2 Start | BioSniper